Niki BioSolutions reported a gross margin of 18.45% and a net margin of -284.05% for the quarter ended Aug 2025. These financial ratios cover 16 quarters of results from Dec 2017 through Aug 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2017 | Dec2018 | Jun2019 | Dec2019 | Jun2020 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | May2024 | Aug2024 | Nov2024 | Aug2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 18.45% | |||||||||||||||
| EBT Margin | -81.52% | -43.33% | -460.26% | |||||||||||||
| EBIT Margin | -71.86% | -35.35% | -575.40% | |||||||||||||
| EBITDA Margin | -65.10% | -28.77% | -555.00% | |||||||||||||
| Operating Margin | -71.86% | -35.35% | -575.40% | |||||||||||||
| Net Margin | -84.41% | -45.41% | -284.05% | |||||||||||||
| FCF Margin | -28.99% | -94.87% | -164.85% | |||||||||||||
| Efficiency | ||||||||||||||||
| Inventory AverageInventory Avg. | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | ||||||||
| Assets AverageAssets Avg. | 0.04B | 0.03B | 0.02B | 0.02B | 0.03B | 0.04B | 0.03B | 0.02B | 0.02B | 0.02B | 0.02B | 0.01B | ||||
| Equity AverageEquity Avg. | 0.03B | 0.03B | 0.02B | 0.02B | 0.03B | 0.03B | 0.02B | 0.02B | 0.01B | 0.01B | 0.01B | 0.01B | -0.01B | -0.01B | ||
| Invested CapitalInvested Cap. | 0.03B | 0.05B | 0.02B | 0.02B | 0.02B | 0.04B | 0.03B | 0.02B | 0.02B | 0.01B | 0.01B | 0.02B | -0.00B | |||
| Leverage & Solvency | ||||||||||||||||
| Interest Coverage RatioInterest Cover | -7.44 | -4.43 | -21.02 | |||||||||||||
| Debt Ratio | 0.02 | 0.30 | 0.00 | 0.26 | 0.10 | 0.05 | 0.03 | 0.00 | 0.12 | 0.31 | 0.01 | 0.15 | 1.06 | |||
| Times Interest Earned | -7.44 | -4.43 | -21.02 | |||||||||||||
| Valuation | ||||||||||||||||
| Price to BookP/B | 129.38 | 291.85 | 309.58 | 62.74 | 20.16 | 37.58 | 30.02 | 30.67 | 2.51 | 0.75 | 0.72 | |||||
| Enterprise Value | -368528.79B | 6.98B | -1509451.41B | 1.09B | 0.73B | 0.97B | -6101222.48B | 0.46B | 0.01B | 0.00B | -0.00B | 0.02B | 0.01B | 0.00B | 0.01B | |
| Market Capitalization | 4.24B | 7.01B | 4.60B | 1.10B | 0.77B | 0.99B | 0.53B | 0.48B | 0.02B | 0.01B | 0.01B | 0.02B | 0.01B | 0.00B | 0.01B | |
| Return Ratios | ||||||||||||||||
| Return on Sales [ROS]ROS | -71.86% | -35.35% | -575.40% |
Pull Niki BioSolutions's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NIKI&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NIKI", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NIKI&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();